Cargando…
Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis
Ovarian cancer (OC) is the most deadly gynecological cancer and it is urgently needed to find a new marker for the progress of OC. Many long noncoding RNAs (lncRNAs) have been reported to be aberrantly expressed in ovarian carcinoma, and may serve as prognostic markers. Therefore, we conducted this...
Autores principales: | Luo, Ping, Liu, Xue-Fang, Wang, Ying-Chao, Li, Nan-Di, Liao, Shen-Jun, Yu, Ming-Xia, Liang, Chun-Zi, Tu, Jian-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410355/ https://www.ncbi.nlm.nih.gov/pubmed/28118613 http://dx.doi.org/10.18632/oncotarget.14760 |
Ejemplares similares
-
Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma
por: Qu, Zhen, et al.
Publicado: (2016) -
The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis
por: Wang, June, et al.
Publicado: (2017) -
The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis
por: Zhang, Wenchao, et al.
Publicado: (2021) -
Prognostic value of lncRNAs in lung carcinoma: a meta-analysis
por: Fan, Fan, et al.
Publicado: (2017) -
The prognostic value of abnormally expressed lncRNAs in prostatic carcinoma: A systematic review and meta-analysis
por: Wu, Xian-Lan, et al.
Publicado: (2017)